baber/WOPTO huggingface dataset:
Patent JP-2000507868-A (JP)
Title: プログラム制御により部屋に香りを送る方法および装置
IPC: G11B19/02
Filed: 1997-04-09
Abstract: (57)【要約】
本発明はプログラム制御によりＴＶルーム、ビデオルーム、ＣＤ−ＲＯＭルーム、映画館、劇場および各種ショーの客席等の部屋へ香りを送る方法および装置に関する。本発明の方法は上演される映画、舞台演劇、芸術ショーかつ／またはミュージカル等の演目に同調かつ同期して部屋へ発散させる一連の香料を含み、部屋へ発散される一連の香料を香りを発生する物質または合成成分の担体により製造し、演目の開始に同期しかつ演目に沿って提供される動作、場所および運動に従って香りを発散させる。本発明はまたこの方法を実行する装置に関する。
Patent JP-H11507449-A (JP)
Title: 非同期バスを同期回路に適応させるための方法及び装置
IPC: G06F13/42
Filed: 1996-05-23
Abstract: (57)【要約】
多くのデジタルプロセッサーが、２つの制御信号（ＥＮＡ’、ＲＷＮ）によって制御される非同期バスを有する。同期メモリを非同期バスと接続するために、インターフェースロジックが必要となる。非同期回路（１）から同期回路（２）へデータ（ＤＡＴＡ）を転送するためのインターフェース（３）において、フリップ−フロップによって、タイミング制御信号（ＥＮＡ’、ＲＷＮ）をシステムクロック（ＣＫＯ）と同期させている間、書き込みデータを中間レジスタ（ＤＲ）に書き込む。対応して、同期回路（２）から非同期回路（１）へデータ（ＤＡＴＡ）を転送するためのインターフェース（４）において、フリップ−フロップ回路によって、同期回路からの読み出しトランザクションを示す信号（ＲＷＮ）をシステムクロックと同期させる。
Patent JP-2001517074-A (JP)
Title: Ｈｉｖ感染と闘うための方法および組成物における改変されたｒｅｖ応答性エレメント（ｒｒｅ）の使用
IPC: G01N33/566
Filed: 1997-04-15
Abstract: (57)【要約】
本発明は、２つの作動性に連結されたHIV Revタンパク質結合部位を含む単離された核酸に関し、この部位は、核形成モチーフおよびオリゴマー化モチーフを含み、ここで、この核酸は、野生型RREよりも高い程度の協同性でRevタンパク質モノマーを結合する。
Patent JP-2001519783-A (JP)
Title: ジアリールエーテルおよびその製造法ならびにそれらを含有する除草および乾燥組成物
IPC: A01N43/80
Filed: 1998-01-14
Abstract: (57)【要約】
一般式(I)：
 （ただし、式中Ｘ、Ｙは独立して水素、ハロゲン、シアノ、ニトロ、または（C 1   〜6 ）ハロアルキルであり、Ｚは酸素または硫黄であり、また、Qは下記基Q 1 ないしQ 9 から選択されるものでる；
                 R 1 はハロゲンである；R 2 、R 3 、R 4 およびR 5 は独立に水素、(C 1   〜6 )アルキル、または（C 1   〜6 ）ハロアルキルである；R 3 およびR 5 は、それらが結合する原子と一緒になる場合には、４ないし７員環の置換もしくは非置換環を表し、該環はO、S(O) n またはN-R 4 により任意に挿入されていてもよく、また、１ないし３個の（C 1   〜6 ）アルキル基または１またはそれ以上のハロゲン原子により任意に置換されていてもよい；R 6 は水素、(C 1   〜6 )アルキル、(C 2   〜6 )アルケニル、(C 2   〜6 )アルキニル、(C 1   〜6 )ハロアルキル、(C 2   〜6 )ハロアルケニル、(C 2   〜6 )ハロアルキニル、(C 1   〜6 )シアノアルキル、(C 1   〜6 )アルコキシ−(C 1   〜6 )アルキル、または(C 1   〜6 )アルキルチオ−(C 1   〜6 ）アルキルである；A 1 およびA 2 は独立に酸素または硫黄である；BはCHまたはNである；R 7 およびR8はそれぞれ独立に、水素、１またはそれ以上のハロゲン原子で任意に置換されてもよい（C 1   〜6 ）アルキル、または１またはそれ以上のハロゲン原子で任意に置換されてもよい（C 3   〜6 ）シクロアルキルであり、また、R 7 およびR 8 は、それらが結合する原子と一緒になる場合には、４ないし７員環の置換もしくは非置換環を表し、該環はO、S(O) n またはN-R 4 により任意に挿入されていてもよく、また、１ないし３個の（C 1   〜6 ）アルキル基または１またはそれ以上のハロゲン原子により任意に置換されていてもよい；ｎは０、１、または２の整数である；R 9 およびR 10 は水素、(C 1   〜6 )アルキル、アシル、または（C 1   〜6 ）アルキルスルホニルであるか、またはR 9 およびR 10 はNR 9 R 10 の窒素原子と共に、(CH 2 ) m 基（mは２、３、４または５）で示されるポリメチレンからなる環を形成してもよく、該環は（C 1   〜6 ）アルキル置換基を有してもよく、または有しなくてもよい；Arは置換または非置換のアリールまたはヘテロアリールである；QがQ 3 またはQ 6 である場合、置換フェニルは除く。）で示される化合物またはその塩。本化合物は雑草の抑制に有用である。
Patent JP-2001523431-A (JP)
Title: Ｕｈｆ領域で動作する無線送受信機たとえばコードレステレフォンの周波数を処理する集積可能な回路
IPC: H04B1/408
Filed: 1999-02-11
Abstract: (57)【要約】
時分割デュプレックスのために周波数ホッピング技術を行う回路コンセプトにおいて、送信経路（４８）と受信経路（６２）のために全体でただ２つの周波数合成装置（４９，５６）しか設けられておらず、また、送信経路中には１つのアップワードミキサ（５４）しか設けられていない。ＵＨＦ合成装置の周波数は、送受信経路中の対応するミキサの重畳周波数として供給される前に分周され、このことで定常化時間が短くなることから、ＵＨＦ周波数合成装置を送信スロットまたは受信スロットのために種々の周波数において使用できるようになる。本発明は、たとえばコードレステレフォンにおいて使用される。
Patent JP-2001502558-A (JP)
Title: モジュラー分岐式血管補綴
IPC: A61F2/07
Filed: 1997-05-28
Abstract: (57)【要約】
本発明は、一本の母管から二本の枝管が分岐して延長するものから成り、その母管の少なくとも一部には膨張性補強材を有することを特徴とする分岐式血管補綴に関する。
Patent JP-2001521503-A (JP)
IPC: A61K31/407
Filed: 1998-03-31
Abstract: Methods are provided for inhibiting stenosis or restenosis following vascular trauma in a mammalian host, comprising administering to the host a therapeutically effective dosage of a cytostatic agent and/or cytoskeletal inhibitor so as to biologically stent the traumatized vessel. Also provided is a method to inhibit or reduce vascular remodeling following vascular trauma, comprising administering an effective amount of a cytoskeletal inhibitor. Further provided are pharmaceutical compositions and kits comprising the therapeutic agents of the invention.
Patent JP-2000508335-A (JP)
Title: 癌の治療方法
IPC: A61K31/215
Filed: 1997-05-27
Abstract: (57)【要約】
本発明は、哺乳動物患者に対してＭＥＫを阻害する化合物及びファルネシルプロテイントランスフェラーゼを阻害する化合物を投与することを含む癌の治療方法に関する。
Patent JP-2001524824-A (JP)
IPC: C07K16/18
Filed: 1998-04-16
Abstract: Novel CRSP polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length CRSP proteins, the invention further provides isolated CRSP fusion proteins, antigenic peptides and anti-CRSP antibodies. The invention also provides CRSP nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a CRSP gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
Patent JP-2001518112-A (JP)
IPC: A61Q1/04
Filed: 1998-03-21
Abstract: Emulsifier-free cosmetic or dermatological preparations, which are finely dispersed systems of the water-in-oil type, comprising1. an oil phase,2. an aqueous phase and3. one or more types of micronized, inorganic pigments whicha) have an average particle size of less than 200 nm, and whose particlesb) have both hydrophilic and lipophilic properties, i.e. have an amphiphilic character, and thus position themselves at the water/oil interface, and whichc) are selected from the group consisting of metal oxides, whichd) are optionally coated on the surfaceand alsooptionally comprising further cosmetic or pharmaceutical auxiliaries, additives and/or active substances.
Patent JP-2000515483-A (JP)
Title: 沈降シリカベースの支持体上に吸着された液体を含む組成物
IPC: A23K1/16
Filed: 1999-03-29
Abstract: (57)【要約】
この発明は、沈降シリカを含む支持体上に吸着された少なくとも一種の液体を含む調整された組成物に関係する(該シリカは、実質的に球形のペレットの形態であり且つ１５０μｍより大きい平均ペレットサイズ；０．２９より小さい密集状態充填密度(ＤＲＴ)；少なくとも８８重量％の７５μｍ未満の孔サイズのふるいに対するオーバーサイズ率；２．０ｃｍ 3 ／ｇより大きい１μｍ未満の直径細孔よりなる多孔質容積(Ｖ dl )を有する)。この発明は又、該シリカの、液体の支持体としての利用にも関係する。
Patent MX-162610-A (MX)
Inventor: WERTZ JEAN-LUC HENRI MARIE
IPC: C11D1/40
Filed: 1983-05-23
Abstract: Detergent compositions, preferably heavy-duty liquids, containing an anionic surfactant, a selected cosurfactant and a fatty acid are disclosed. The compositions are formulated to provide an initial pH of from about 6.0 to about 8.5 at a concentration of from about 0.1% to about 2% by weight in water at 20 DEG C. The compositions preferably also contain ethoxylated nonionic surfactants, a detergent builder and enzymes.
Patent NZ-196284-A (NZ)
Title: 1-piperazino-3-phenylindane derivatives:pharmaceutical compositions
Inventor: BOGESO K P
IPC: C07D295/00
Filed: 1981-02-17
Abstract: 1-Piperazino-3-phenylindane derivatives of the formula: 
<CHEM>
 wherein R<1>, R<2>, R<3> and R<4> are as defined in Claim 1, and their pharmaceutically acceptable acid addition salts. 
<??>The compounds are prepared by the usual methods for analogous compounds. 
<??>They have been found to have psychopharmacological and analgetic activity. 
<??>Pharmaceutical compositions containing the compounds have been disclosed.
Patent NZ-200861-A (NZ)
Title: Wound secretion-drainage catheter with inner and outer lumen
Inventor: EKBLADH F V G
IPC: A61M27/00
Filed: 1982-06-04
Abstract: The present invention relates to a catheter intended for postsurgical drainage of a wound area after a surgical incision and particularly such a catheter which is connected to a wound secretion receiver being provided with a vacuo. The catheter is characterized in that it at its front end is provided with at least one slot (6), which extends along the catheter (1), whereby throughopenings (9) are arranged from the bottom of the slot (6) to a lumen (2) arranged centrally in the catheter (1). Using the present invention no suction-in of tissue into the lumen (2) of the catheter (1) will occur but the catheter can be removed without applying any greater force and without obtaining any trauma in the wound.
Patent NZ-209896-A (NZ)
Title: 5-hydroxymethyl-2-mercapto-imidazoles preparation of 5-formyl-imidazoles
Inventor: PARHI S S L
IPC: A61K31/415
Filed: 1984-10-16
Abstract: The invention provides novel 1-substituted-5-hydroxymethyl-2-mercapto-imidazoles of the formula <IMAGE> (I)  wherein R is pyridylmethyl, alkyl of 1 to 4 carbon atoms, or a radical of formula:  <IMAGE>  in which R1 is hydrogen or halogen and n is 1-3. These compounds are prepared by reacting together dihydroxyacetone dimer, the amine R-NH2, and potassium thiocyanate. The compounds of formula (I) are useful as starting materials in the preparation of known therapeutically valuable imidazole derivatives, by removing the mercapto group, oxidizing the alcohol group to an aldehyde group and condensing the aldehyde with an appropriate phenyl or phenylalkyl magnesium halide.
Patent NZ-229894-A (NZ)
Title: Polymer polyol compositions and use in polyurethane foams
Inventor: HAGER STANLEY LEE
IPC: C08L71/02
Filed: 1989-07-11
Abstract: Polymer polyol compositions are provided which are useful for the production of flexible polyurethane foams. The polymer polyol compositions are composed of (1) a high functionality polyol, (2) a subsidiary polyalkylene oxide high in polyoxyethylene content and (3) a stably dispersed polymer. The latter component is formed by in situ polymerization of low molecular weight compounds within components (1) and/or (2) used in making the polymer polyol composition. The polymer polyol compositions provide stable and non-shrinking, free-rise foam at high water levels and over a wider crosslinker and index range permitting increased density and load latitude relative to commercial high resilience polymer polyols. A process for their use and foams and articles prepared therefrom are also provided.
Patent NZ-231243-A (NZ)
Title: Diphenylalkylamide derivatives and pharmaceutical compositions thereof
Inventor: SJOGREN CHRISTER
IPC: C07C233/78
Filed: 1989-11-02
Abstract: The invention concerns compounds having the formula I <CHEM> wherein Ar is a phenyl or benzyl group which is optionally substituted with hydroxy or alkoxy;  R<1> is hydrogen, lower alkyl, lower alkoxy, hydroxy;  R<2> is hydrogen, lower alkyl;  R<3> is NR<4>R<5>, wherein R<4> and R<5> which can be the same or different, are lower alkyl, or wherein R<4> and R<5>, when taken together, form a ring with the nitrogen atom, whereby said ring optionally is substituted with lower alkyl;  n is 0 or 1;  m is 2 or 3 and their salts with physiologically acceptable acids and when the compounds can be in form of optical isomers, the racemic mixture and the individual isomers, for the treatment of disorders of the urinary bladder.
Patent NZ-232508-A (NZ)
Title: Clarifying liquid by adding flocculant and an inert particulate carrier
Inventor: BROWNE GEOFFREY ROBERT
IPC: C02F1/52
Filed: 1990-02-13
Abstract: A process for clarifying liquors containing suspended solids comprising adding inert particulate carrier and a flocculent to the liquor. The amount of inert particulate carrier added is selected such that the weight ratio of the inert particulate carrier to suspended solids is above a minimum value necessary to cause substantial clarification of the liquor. The process is based on the realisation that the ratio has a significant influence on the clarification of liquors.
Patent NZ-239958-A (NZ)
Title: Membrane formed by zeo-type material on porous support sigma-
Inventor: BARRI SAMI ALI IBRAHIM
IPC: B01J29/06
Filed: 1991-09-26
Abstract: Novel membranes comprise crystals of a zeo-type material carried by a porous support. The crystal growth of the zeo-type material is essentially continuous over the pores of the support and the zeo-type material is crystallised directly from and bonds directly to the support. Membranes may be prepared by immersing the support in a synthesis gel, crystallising the gel, removing the support, and repeating these steps at least once. <IMAGE>
Patent NZ-247355-A (NZ)
Title: Treatment of plants by introducing active ingredient into the sap-conducting parts of a plant in a solid carrier material
Inventor: TSUBOI SHIN-ICHI
IPC: A01N25/00
Filed: 1993-04-07
Abstract: The present invention relates to a process for the treatment of individual plants with solid shaped plant treatment agents which are introduced into the sap conduction paths of the plants, new solid shaped plant treatment agents and their production.
Patent NZ-253631-A (NZ)
Title: Phosphonate or nsaid pharmaceutical compositions for treating arthritis
Inventor: HOVANCIK KRISTINE
IPC: A61K31/19
Filed: 1993-06-14
Abstract: The present invention provides methods of treating a human or other animal subject afflicted with arthritis, including rheumatoid, arthritis and osteoarthritis, comprising a sixty (60)-day treatment period, comprised of an optional NSAID administration regimen and a phosphonate administration regimen, wherein (a) said optional NSAID administration regimen which comprises the administration to said subject of NSAIDs at a level of from 20% to 80%, preferably 20% to 70%, most preferably 20% to 50% of the conventionally prescribed daily dose on each day that said NSAID is administered; provided that said NSAID is administered in sufficient quantities and on a sufficient number of days to alleviate symptoms of inflammation, and wherein (b) said phosphonate administration regimen comprises the administration to said subject of a phosphonate at a dose equivalent to a systemic level of from about 0.0005 mgP/kg to about 1.0 mgP/kg per day that said phosphonate is administered; provided that said phosphonate is administered at least 1 day of every said sixty (60)-day treatment period.
Patent NZ-254239-A (NZ)
Title: Plastic kneading and extruding apparatus with extruders revolved around central support to allow simultaneous extruder operation and cleaning of other extruders
Inventor: SASAKI BEJI
IPC: B29C48/27
Filed: 1993-07-19
Abstract: A method of and an apparatus for knead-extruding a plastic resin which are free from the drawbacks encountered in conventional method and apparatus of this kind, and which have a high extrusion operation efficiency, the apparatus being provided with a single auxiliary unit having a screw driving power source and a resin hopper, and a plurality of extrusion units each of which has a resin inlet-carrying cylinder and a screw, the operation of each extrusion unit consisting of an extrusion step for knead-extruding a resin, and a cleaning step for cleaning the screws and cylinders, the extrusion step and cleaning step being carried out alternately in order in each extrusion unit. This invention enables an integrated continuous extrusion operation to be carried out without causing the extrusion steps to be interrupted by the cleaning steps. <IMAGE>
Patent NZ-258406-A (NZ)
Title: Receiver for reception of interactive multimedia over telephone network
Inventor: LEWIS SCOTT W
IPC: H04N21/4143
Filed: 1993-11-11
Abstract: A system and device is provided that enhances the interactivity of multimedia information across a communications network or in combination with other networks including telecommunication and cable broadcasting. The system includes an interactive multimedia mastering (IMM) system for receiving multimedia program materials from a program source, a multimedia call processing system (MCPS) coupled to the IMM, and a plurality of interactive multimedia devices (IMDs) for distributing multimedia information to users. The IMM optimizes the program materials by separating the information into primary and secondary layers using psychographic parameters to differentiate between important and less important multimedia information, and then compresses at least a portion of the layers for transmission to the MCPS. The IMDs accept user commands for multimedia information from a telephone, which cause the IMD to transmit a control signal to the MCPS. The MCPS receives the control signal while in a voice mode, and in response, branches to a program branch in the optimized program materials indicated by the control signal. The MCPS switches to a data mode for transmitting data from the indicated program branch back to the requesting IMD, and then switches back to the voice mode to accept further control signals from the IMD. Once the IMD receives the materials, the IMD decompresses any compressed portions and mixes the decompressed portions with the uncompressed portions to provide enhanced interactive multimedia information to the user.
Patent NZ-264616-A (NZ)
Title: Compositions for treating myopia containing a 7-alkyl-5-oxo-benzopyrano[2,3-b]pyridine derivative
Inventor: SHIGEMITSU TOSHIRO
IPC: A61K31/535
Filed: 1994-10-05
Abstract: A use of a compound of the formula <CHEM> wherein R is an alkyl, R<1> is a hydrogen or an amino and R<2> is a carboxyl or a tetrazole, or a salt thereof for the production of a composition for the prophylaxis and treatment of myopia. The use for the prophylaxis and treatment of myopia of the present invention not only results in relaxing action on the ciliary smooth muscle of rabbit, but also brings about superior effects of prevention and treatment of myopia of the patients on whom Mydrin-M, a conventional preparation for the prophylaxis and treatment of myopia, failed to have effects. In addition, the use does not involve a mydriatic response and is advantageous for the prophylaxis and treatment of myopia.
Patent NZ-282568-A (NZ)
Title: Use of condensed aminoacetylmercaptobenzazepines in treating elevated cholesterol levels, atherosclerosis, and hypotriglyceridemia
Inventor: FLYNN GARY ALAN
IPC: C07K5/078
Filed: 1995-02-28
Abstract: The present invention relates to the use of certain aminoacetylmercapto derivatives in treating patients suffering from hypertriglyceridemia, atherosclerosis and hypercholesterolemia.
Patent NZ-305785-A (NZ)
Title: A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of cancers
Inventor: CAMDEN JAMES BERGER
IPC: A61K45/06
Filed: 1997-10-09
Abstract: N-chlorophenylcarbarmate or N-chlorophenylthiocarbarmate of the formula with n being from 1 to 3, X being oxygen or sulfur, and R being hydrogen, lower alkyl, lower alkenyl, cyclohexl, phenyl, or phenalkyl of up to 8 carbon atoms, is useful for making medicine for treatment of breast, colon, non-small cell lung, or ovarian cancer or tumors.
Patent NZ-323604-A (NZ)
Title: Enteral feeding tube system used to assist in tube placement
Inventor: TOMBA TODD C
IPC: A61B5/296
Filed: 1996-11-21
Abstract: A system and method are described in which myoelectric signals within a patient's body are detected by electrodes secured to the distal end of a gastrointestinal feeding tube, and are promptly displayed by some means and made available to a medical care provider while placing the tube in the patient. The signals detected indicate where the distal end of the tube is located within the gastrointestinal tract at any moment during the insertion of the tube into a patient's body.
Patent NZ-330567-A (NZ)
Title: Optical switch using electro-optical crystal with at least two collinear optical signals and at least one control beam
Inventor: BOFFI PIERPAOLO
IPC: H04B10/27
Filed: 1998-06-04
Abstract: n optical switching device includes an elementary switching module 2000.  This consists of a crystalline element without internal planes of separation which is capable of rotating the plane of polarisation of a polarised optical  signal by a predetermined angle under the action of at least one control beam.  A polarisation analyzer 20 selects, according to a predetermined plane the polarised signal from the crystalline element.  The polarised optical signal consists of at least two different polarised optical signals, such as signals 11, 12, 13, and 14.  The control beam 310 is collinear with the polarised optical signals and superimposed upon them.  The crystalline element may be a monocrystal of indium -doped cadmium telluride, and may have electrodes for applying a voltage across the crystal so as to rotate the plane of polarisation of the two optical signals.
Patent NZ-331488-A (NZ)
Title: Caramels containing a sweetener comprising 1(or 6)-o-<alpha>-d-glucopyranosyl-d-sorbitol (or mannitol)
Inventor: WILLIBALD-ETTLE INGRID
IPC: A23L27/30
Filed: 1997-02-21
Abstract: The invention relates to confections, in particular hard and soft confections, which contain a sweetener of 1-O-alpha-D-glucopyranosyl-D-sorbitol (1,1 GPS), in particular 6-O-alpha-D-glucopyranosyl-D-sorbitol (1,6 GPS), 1-O-alpha-D-glucopyranosyl-D-sorbitol (1,1 GPS) and 1-O-alpha-D-glucopyranosyl-D-mannitol (1,1 GPM); and to the use of this sweetener in confections, in particular pharmaceutically active confections.
Patent NZ-334865-A (NZ)
Title: An implement for automatically milking animals comprises a cleaning device connected to a rinsing fluid tank via a cleaning fluid line
Inventor: VAN DEN BERG KAREL
IPC: A01J7/04
Filed: 1998-07-01
Abstract: An implement for automatically milking animals, such as cows comprises a rinsing circuit for at least cleaning the teat cups (1), wash lines (43) and milk lines (2).  In the rinsing circuit there is included a rinsing fluid tank (16).  The implement is further provided with at least one cleaning member (45) with the aid of which the teats and/or the udder of the animal are cleaned, as well as a cleaning device (44) for cleaning the cleaning member (45).  Cleaning device (44) is connected to rinsing fluid tank (16) via a cleaning supply line.
Patent NZ-504695-A (NZ)
Title: Vinyl acetate catalyst comprising metallic palladium and gold, and cupric acetate
Inventor: NICOLAU IOAN
IPC: B01J23/52
Filed: 1998-10-12
Abstract: A catalyst for the production of vinyl acetate by reaction of ethylene, oxygen and acetic acid comprising a porous support on the porous surfaces of which is deposited catalytically effective amounts of metallic palladium and gold, and cupric acetate.  Use of this catalyst results in a reaction having a relatively low selectivity to carbon dioxide.
Patent NZ-506567-A (NZ)
Title: A metal track for steel stud walls being "U" shaped sections interconnected by integral flexible strips to curve in longitudinal direction
Inventor: CARIOLATO SERGIO
IPC: E04B9/00
Filed: 2000-08-25
Abstract: Track 20 is formed as adjacent "U" shaped sections separated/connected by slots and flexible webs 28,31. Track 20 can be bent to follow a curve, and is noted to be useful for curved steel stud walls.
Patent NZ-515454-A (NZ)
Title: Pyrazinone thrombin inhibitors
Inventor: BURGEY CHRISTOPHER
IPC: A61K31/495
Filed: 2000-06-01
Abstract: Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having structure (I), wherein A is a substituted pyridine ring and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for use as thrombin inhibitors.
Patent NZ-516371-A (NZ)
Title: Annexin derivatives with endogenous chelation sites
Inventor: TAIT JONATHAN F
IPC: A61K51/00
Filed: 2000-05-25
Abstract: Modified annexins having an N-terminal chelation site comprising an amino acid extension that contains an amino acid sequence X1-Gly-X2, where X1 and X2 are selected from Gly and Cys and where at least one of X1 or X2 is Cys.  The modified annexins are used for imaging vascular thrombi and apoptosis in vivo.
Patent NZ-519987-A (NZ)
Title: Novel compounds having analgesic effects
Inventor: BROWN WILLIAM
IPC: A61P25/04
Filed: 2000-12-15
Abstract: compound of formula (I), wherein: R1 is selected from any one of phenyl, pyridinyl, thienyl, furanyl, imidazolyl, and triazolyl; where each R1 phenyl ring and R1 heteroaromatic ring may optionally and independently be further substituted by 1, 2 or 3 substituents selected from straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo. The substitutions on the phenyl ring and on the heteroaromatic ring may take place in any position on said ring systems; Ra and Rb is each and individually selected from any one of hydrogen, a straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo; as well as their pharmaceutically acceptable salts and pharmaceutical compositions comprising these compounds and their use in therapy, in particular in the management of pain is disclosed.